Enforcing irf7 expression by tumor cells could restore type I IFN signaling, leading to inhibition of metastatic dissemination in the 4T1.2 breast cancer bone metastasis model (Lelekakis et al., 1999; Eckhardt et al., 2005). This evidence concerns the gene IRF7 and neoplasm.